HomeNewsBusinessAir travellers in pre-COVID mode as pandemic fears ebb; industry seeks end of govt curbs

Air travellers in pre-COVID mode as pandemic fears ebb; industry seeks end of govt curbs

Industry experts and airline executives say the government should ease curbs on pricing and capacity utilisation to align its approach with market realities.

September 06, 2021 / 22:44 IST
Story continues below Advertisement
Representative image (Source: ShutterStock)
Representative image (Source: ShutterStock)

Increasing vaccination and declining COVID-19 cases in most parts of India have given travellers the confidence to book air tickets weeks in advance instead of flying at short notice because of lockdowns or emergencies.

Industry experts and airline executives say that in view of the changed customer behaviour, the government should ease the restriction on capacity utilization and fares, which was imposed to help the smaller carriers withstand the disruption caused by the pandemic.

Story continues below Advertisement

Airlines are allowed to sell seats up to 72.5 percent of their capacity of a schedule during a season and the minimum and maximum fares for the shortest flights, Class A, have been set at Rs 2,900 and Rs 8,800, respectively.

Changing customer behaviour?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show